Toward a Biological Therapy to Improve Stroke Outcomes After Thrombolytic Therapy
- PMID: 26508732
- DOI: 10.1161/CIRCULATIONAHA.115.019446
Toward a Biological Therapy to Improve Stroke Outcomes After Thrombolytic Therapy
Keywords: Editorials; acute stroke; cerebral ischemia-reperfusion injury; stroke management; thrombolytic therapy.
Comment on
-
Genetic Ablation of Extra Domain A of Fibronectin in Hypercholesterolemic Mice Improves Stroke Outcome by Reducing Thrombo-Inflammation.Circulation. 2015 Dec 8;132(23):2237-47. doi: 10.1161/CIRCULATIONAHA.115.016540. Epub 2015 Oct 27. Circulation. 2015. PMID: 26508731 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
